Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Cl.Rb |
| Molecular Weight | 120.921 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Rb+]
InChI
InChIKey=FGDZQCVHDSGLHJ-UHFFFAOYSA-M
InChI=1S/ClH.Rb/h1H;/q;+1/p-1
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3311597 | https://www.ncbi.nlm.nih.gov/pubmed/26442267
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3311597 | https://www.ncbi.nlm.nih.gov/pubmed/26442267
Rubidium chloride is an inorganic compound with the formula RbCl. It appears to be nontoxic and therapeutically effective in several types of depressive disorders. This drug develops his action on dopaminergic stimulation reducing the depressive pattern. Also radioactive rubidium-82 chloride is used as diagnostic agent in positron emission tomography (PET).
CNS Activity
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Protein kinase C-epsilon modulates mitochondrial function and active Na+ transport after oxidant injury in renal cells. | 2004-02 |
|
| Gating properties of inward-rectifier potassium channels: effects of permeant ions. | 2001-11-01 |
|
| Inhibition of HIV-1 infection by zinc group metal compounds. | 1999-09 |
|
| Effects of trace metal compounds on HIV-1 reverse transcriptase: an in vitro study. | 1999-05 |
|
| Exploration of the clinical profile of rubidium chloride in depression: a systematic open trial. | 1988-06 |
|
| Nerve fibre refractory period in patients treated with rubidium and lithium. | 1978-09 |
|
| Effects of rubidium chloride on the course of manic-depressive illness. | 1978-05 |
|
| Rubidium chloride ingestion by volunteer subjects: initial experience. | 1971 |
|
| Brain norepinephrine: enhanced turnover after rubidium treatment. | 1970-04-24 |
Patents
Sample Use Guides
Rubidium chloride accelerated cAMP synthesis in rat brain cortex membranes. The effect was dose-dependent and yielded above 2-fold activation of adenylate cyclase. It has been shown that Rb+ influenced directly the catalytic subunit of the enzyme and did not substitute Mg2+ in formation of the metal-ATP complex in this reaction. The stimulatory effect of Rb+ was additive to the activation of adenylate cyclase by the half-maximal (0.3 microM) as well as by the saturating (10 microM) forskolin concentrations, pointing to the fact that these effectors activate different isoforms of the enzyme in rat brain cortex.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
1946 (Number of products:63)
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
232-240-9
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
100000078861
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
m9687
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | Merck Index | ||
|
C032710
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
N3SHC5273S
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
84273
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
78672
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
RUBIDIUM CHLORIDE
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
1367087
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | RxNorm | ||
|
7791-11-9
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
62683
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
SUB15161MIG
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
DTXSID5064881
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
N3SHC5273S
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
